BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37432966)

  • 1. Jellybean-Induced Intoxication: A Case Series of Unintentional Synthetic Cannabinoid Exposure in Children and Adults.
    Az A
    Am J Forensic Med Pathol; 2023 Dec; 44(4):358-361. PubMed ID: 37432966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute intoxication caused by synthetic cannabinoids 5F-ADB and MMB-2201: A case series.
    Barceló B; Pichini S; López-Corominas V; Gomila I; Yates C; Busardò FP; Pellegrini M
    Forensic Sci Int; 2017 Apr; 273():e10-e14. PubMed ID: 28190538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic Cannabinoid Abuse in Adolescents: A Case Series.
    Besli GE; Ikiz MA; Yildirim S; Saltik S
    J Emerg Med; 2015 Nov; 49(5):644-50. PubMed ID: 26293411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoid hyperemesis: a case series.
    Donnino MW; Cocchi MN; Miller J; Fisher J
    J Emerg Med; 2011 Apr; 40(4):e63-6. PubMed ID: 19765941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of clinical manifestations in adolescent and young adults after use of synthetic cannabinoids.
    Brewer TL; Collins M
    J Spec Pediatr Nurs; 2014 Apr; 19(2):119-26. PubMed ID: 24320158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Common Source Outbreak of Severe Delirium Associated with Exposure to the Novel Synthetic Cannabinoid ADB-PINACA.
    Schwartz MD; Trecki J; Edison LA; Steck AR; Arnold JK; Gerona RR
    J Emerg Med; 2015 May; 48(5):573-80. PubMed ID: 25726258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid Hyperemesis Syndrome: Reports of Fatal Cases.
    Nourbakhsh M; Miller A; Gofton J; Jones G; Adeagbo B
    J Forensic Sci; 2019 Jan; 64(1):270-274. PubMed ID: 29768651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid Hyperemesis Syndrome: An Unexpected Problem in an Unusual Setting-A Case Report.
    Stuart R; Richards JR
    Mil Med; 2020 Sep; 185(9-10):e1894-e1896. PubMed ID: 32472123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabinoid hyperemesis syndrome: literature review and proposed diagnosis and treatment algorithm.
    Wallace EA; Andrews SE; Garmany CL; Jelley MJ
    South Med J; 2011 Sep; 104(9):659-64. PubMed ID: 21886087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resolution of Cannabinoid Hyperemesis Syndrome with Benzodiazepines: A Case Series.
    Kheifets M; Karniel E; Landa D; Vons SA; Meridor K; Charach G
    Isr Med Assoc J; 2019 Jun; 21(6):404-407. PubMed ID: 31280510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid hyperemesis syndrome: a case series and review of previous reports.
    Nicolson SE; Denysenko L; Mulcare JL; Vito JP; Chabon B
    Psychosomatics; 2012; 53(3):212-9. PubMed ID: 22480624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Case Report on Cannabinoid Hyperemesis Syndrome in Palliative Care: How Good Intentions Can Go Wrong.
    Senderovich H; Waicus S
    Oncol Res Treat; 2022; 45(7-8):438-443. PubMed ID: 35504245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cannabinoid hyperemesis syndrome causing prolonged nausea and vomiting in patients with cannabis abuse].
    Naver AV; Theede K
    Ugeskr Laeger; 2015 Apr; 177(18):. PubMed ID: 25922240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoid Hyperemesis Syndrome in a 17-Year-Old Adolescent.
    Desjardins N; Jamoulle O; Taddeo D; Stheneur C
    J Adolesc Health; 2015 Nov; 57(5):565-7. PubMed ID: 26372366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy.
    Smith LA; Azariah F; Lavender VT; Stoner NS; Bettiol S
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD009464. PubMed ID: 26561338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is haloperidol the wonder drug for cannabinoid hyperemesis syndrome?
    Inayat F; Virk HU; Ullah W; Hussain Q
    BMJ Case Rep; 2017 Jan; 2017():. PubMed ID: 28052951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic cannabinoid use among college students.
    Mathews EM; Jeffries E; Hsieh C; Jones G; Buckner JD
    Addict Behav; 2019 Jun; 93():219-224. PubMed ID: 30772774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal manifestations of synthetic cannabinoids: a retrospective cohort study.
    Hakimian D; Benson AA; Khoury T; Massarwa M; Israel S; Salameh S; Gershinsky Y; Shapira B; Muszkat M
    BMC Gastroenterol; 2021 Jul; 21(1):274. PubMed ID: 34229620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of cannabinoid hyperemesis syndrome caused by synthetic cannabinoids.
    Hopkins CY; Gilchrist BL
    J Emerg Med; 2013 Oct; 45(4):544-6. PubMed ID: 23890687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoid hyperemesis syndrome: a case report and review of pathophysiology.
    Iacopetti CL; Packer CD
    Clin Med Res; 2014 Sep; 12(1-2):65-7. PubMed ID: 24667219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.